News & Updates

Sexual dysfunction affects >50 percent of patients with schizophrenia
Sexual dysfunction affects >50 percent of patients with schizophrenia
09 Nov 2023 byKanas Chan

Sexual dysfunction is highly prevalent in schizophrenia, affecting >50 percent of patients. Treatment of comorbid depression may be an effective strategy to improve sexual health, according to a meta-analysis.

Sexual dysfunction affects >50 percent of patients with schizophrenia
09 Nov 2023
Survey reveals an overview of patient experience with pDPN
Survey reveals an overview of patient experience with pDPN
09 Nov 2023
Neoadjuvant immunotherapy delivers better response in NSCLC
Neoadjuvant immunotherapy delivers better response in NSCLC
08 Nov 2023 byStephen Padilla

Patients with nonsmall cell lung cancer (NSCLC) who have been treated with neoadjuvant immunotherapy show greater response than those treated with neoadjuvant chemotherapy (CT), as shown in a study. Treatment-related adverse events (TRAEs) are similar between the two groups.

Neoadjuvant immunotherapy delivers better response in NSCLC
08 Nov 2023
Serum vitamin A, E forms tied to prostate cancer risk
Serum vitamin A, E forms tied to prostate cancer risk
08 Nov 2023 byAudrey Abella

Several forms of serum vitamin A and E were associated with prostate cancer risk, with significant effect modification by smoking and alcohol consumption status, according to an analysis that used data from the Singapore Prostate Cancer Study.

Serum vitamin A, E forms tied to prostate cancer risk
08 Nov 2023